default author photo

Joyce Plested

Novavax, Inc. - Clinical Immunology Laboratory

SCHOLARLY PAPERS

2

DOWNLOADS

255

TOTAL CITATIONS

3

Scholarly Papers (2)

1.

Safety and Immunogenicity of SII-NVX-CoV2373 (COVID-19 Vaccine) In Adults in a Phase 2/3, Observer-Blind, Randomised, Controlled Study

Number of pages: 31 Posted: 08 Jul 2022
Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR) - National AIDS Research Institute, Indian Council of Medical Research (ICMR) - National AIDS Research Institute, Dr. D. Y. Patil Medical College, Hospital & Research Centre - Dr. D. Y. Patil Medical College, Hospital & Research Centre, Students, Mahatma Gandhi Institute of Medical Sciences, Hamdard Institute of Medical Sciences & Research (HIMSR), University of Liverpool - School of Tropical Medicine, JSS Academy of Higher Education and Research, Institute of Medical Sciences & SUM Hospital, KLES Dr. Prabhakar Kore Hospital & M.R.C, KEM Hospital Research Centre - Vadu Budruk, Seth G S Medical College & KEM Hospital, Government Medical College, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), KIIT University - Kalinga Institute of Medical Sciences (KIMS), KIMS Hospital and Research Centre, Christian Medical College, Sahyadri Super Specialty Hospital, Pune, Acharya Vinoba Bhave Rural Hospital, Amrita Institute of Medical Science - Division of Infectious Disease, Noble Hospital, All India Institute of Medical Sciences (AIIMS), Bhopal, All India Institute of Medical Sciences (AIIMS), Gorakhpur, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, 360biolabs, Indian Council of Medical Research (ICMR), Indian Council of Medical Research–National AIDS Research Institute, Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR), Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Indian Council of Medical Research (ICMR), Serum Institute of India Private Ltd, Serum Institute of India Private Ltd and Independent
Downloads 163 (461,984)
Citation 1

Abstract:

Loading...

SII-NVX-CoV2373, NVX-CoV2373, safety, immunogenicity, non-inferiority

2.

Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2: A High-Throughput Method for Evaluation of Vaccine Immunogenicity

Number of pages: 22 Posted: 01 Feb 2024
Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory, Novavax, Inc. - Clinical Immunology Laboratory and Novavax, Inc. - Clinical Immunology Laboratory
Downloads 92 (742,061)
Citation 2

Abstract:

Loading...

neutralization, pseudovirus, COVID-19, variant, validation, correlates of protection